New York, NY, United States of America

Michel Bazinet

This inventor holds 2 USPTO granted patents. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 1990-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Bazinet. Retrieved from https://idiyas.com/inventor/michel-bazinet-h3qyjsxy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1990-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Michel Bazinet

Introduction: Michel Bazinet is a renowned inventor based in New York, NY, known for his groundbreaking contributions to various industries.

Latest Patents: Michel Bazinet holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovations.

Career Highlights: Throughout his career, Michel Bazinet has been recognized for his innovative solutions that have revolutionized the way we live and work. His inventions have significantly impacted the market and improved the quality of life for many.

Collaborations: Michel Bazinet has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His partnerships have been instrumental in the successful development and commercialization of his patented technologies.

Conclusion: Michel Bazinet's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire future generations of innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…